Cargando…

Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells

AIMS/HYPOTHESIS: Transcriptome analyses revealed insulin-gene-derived transcripts in non-beta endocrine islet cells. We studied alternative splicing of human INS mRNA in pancreatic islets. METHODS: Alternative splicing of insulin pre-mRNA was determined by PCR analysis performed on human islet RNA a...

Descripción completa

Detalles Bibliográficos
Autores principales: van Tienhoven, René, Kracht, Maria J. L., van der Slik, Arno R., Thomaidou, Sofia, Wolters, Anouk H. G., Giepmans, Ben N. G., Riojas, Juan Pablo Romero, Nelson, Michael S., Carlotti, Françoise, de Koning, Eelco J. P., Hoeben, Rob C., Zaldumbide, Arnaud, Roep, Bart O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036285/
https://www.ncbi.nlm.nih.gov/pubmed/36884057
http://dx.doi.org/10.1007/s00125-023-05882-y
_version_ 1784911617313472512
author van Tienhoven, René
Kracht, Maria J. L.
van der Slik, Arno R.
Thomaidou, Sofia
Wolters, Anouk H. G.
Giepmans, Ben N. G.
Riojas, Juan Pablo Romero
Nelson, Michael S.
Carlotti, Françoise
de Koning, Eelco J. P.
Hoeben, Rob C.
Zaldumbide, Arnaud
Roep, Bart O.
author_facet van Tienhoven, René
Kracht, Maria J. L.
van der Slik, Arno R.
Thomaidou, Sofia
Wolters, Anouk H. G.
Giepmans, Ben N. G.
Riojas, Juan Pablo Romero
Nelson, Michael S.
Carlotti, Françoise
de Koning, Eelco J. P.
Hoeben, Rob C.
Zaldumbide, Arnaud
Roep, Bart O.
author_sort van Tienhoven, René
collection PubMed
description AIMS/HYPOTHESIS: Transcriptome analyses revealed insulin-gene-derived transcripts in non-beta endocrine islet cells. We studied alternative splicing of human INS mRNA in pancreatic islets. METHODS: Alternative splicing of insulin pre-mRNA was determined by PCR analysis performed on human islet RNA and single-cell RNA-seq analysis. Antisera were generated to detect insulin variants in human pancreatic tissue using immunohistochemistry, electron microscopy and single-cell western blot to confirm the expression of insulin variants. Cytotoxic T lymphocyte (CTL) activation was determined by MIP-1β release. RESULTS: We identified an alternatively spliced INS product. This variant encodes the complete insulin signal peptide and B chain and an alternative C-terminus that largely overlaps with a previously identified defective ribosomal product of INS. Immunohistochemical analysis revealed that the translation product of this INS-derived splice transcript was detectable in somatostatin-producing delta cells but not in beta cells; this was confirmed by light and electron microscopy. Expression of this alternatively spliced INS product activated preproinsulin-specific CTLs in vitro. The exclusive presence of this alternatively spliced INS product in delta cells may be explained by its clearance from beta cells by insulin-degrading enzyme capturing its insulin B chain fragment and a lack of insulin-degrading enzyme expression in delta cells. CONCLUSIONS/INTERPRETATION: Our data demonstrate that delta cells can express an INS product derived from alternative splicing, containing both the diabetogenic insulin signal peptide and B chain, in their secretory granules. We propose that this alternative INS product may play a role in islet autoimmunity and pathology, as well as endocrine or paracrine function or islet development and endocrine destiny, and transdifferentiation between endocrine cells. INS promoter activity is not confined to beta cells and should be used with care when assigning beta cell identity and selectivity. DATA AVAILABILITY: The full EM dataset is available via www.nanotomy.org (for review: http://www.nanotomy.org/OA/Tienhoven2021SUB/6126-368/). Single-cell RNA-seq data was made available by Segerstolpe et al [13] and can be found at https://sandberglab.se/pancreas. The RNA and protein sequence of INS-splice was uploaded to GenBank (BankIt2546444 INS-splice OM489474). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05882-y) contains peer-reviewed but unedited supplementary material..
format Online
Article
Text
id pubmed-10036285
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-100362852023-03-25 Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells van Tienhoven, René Kracht, Maria J. L. van der Slik, Arno R. Thomaidou, Sofia Wolters, Anouk H. G. Giepmans, Ben N. G. Riojas, Juan Pablo Romero Nelson, Michael S. Carlotti, Françoise de Koning, Eelco J. P. Hoeben, Rob C. Zaldumbide, Arnaud Roep, Bart O. Diabetologia Article AIMS/HYPOTHESIS: Transcriptome analyses revealed insulin-gene-derived transcripts in non-beta endocrine islet cells. We studied alternative splicing of human INS mRNA in pancreatic islets. METHODS: Alternative splicing of insulin pre-mRNA was determined by PCR analysis performed on human islet RNA and single-cell RNA-seq analysis. Antisera were generated to detect insulin variants in human pancreatic tissue using immunohistochemistry, electron microscopy and single-cell western blot to confirm the expression of insulin variants. Cytotoxic T lymphocyte (CTL) activation was determined by MIP-1β release. RESULTS: We identified an alternatively spliced INS product. This variant encodes the complete insulin signal peptide and B chain and an alternative C-terminus that largely overlaps with a previously identified defective ribosomal product of INS. Immunohistochemical analysis revealed that the translation product of this INS-derived splice transcript was detectable in somatostatin-producing delta cells but not in beta cells; this was confirmed by light and electron microscopy. Expression of this alternatively spliced INS product activated preproinsulin-specific CTLs in vitro. The exclusive presence of this alternatively spliced INS product in delta cells may be explained by its clearance from beta cells by insulin-degrading enzyme capturing its insulin B chain fragment and a lack of insulin-degrading enzyme expression in delta cells. CONCLUSIONS/INTERPRETATION: Our data demonstrate that delta cells can express an INS product derived from alternative splicing, containing both the diabetogenic insulin signal peptide and B chain, in their secretory granules. We propose that this alternative INS product may play a role in islet autoimmunity and pathology, as well as endocrine or paracrine function or islet development and endocrine destiny, and transdifferentiation between endocrine cells. INS promoter activity is not confined to beta cells and should be used with care when assigning beta cell identity and selectivity. DATA AVAILABILITY: The full EM dataset is available via www.nanotomy.org (for review: http://www.nanotomy.org/OA/Tienhoven2021SUB/6126-368/). Single-cell RNA-seq data was made available by Segerstolpe et al [13] and can be found at https://sandberglab.se/pancreas. The RNA and protein sequence of INS-splice was uploaded to GenBank (BankIt2546444 INS-splice OM489474). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00125-023-05882-y) contains peer-reviewed but unedited supplementary material.. Springer Berlin Heidelberg 2023-03-08 2023 /pmc/articles/PMC10036285/ /pubmed/36884057 http://dx.doi.org/10.1007/s00125-023-05882-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
van Tienhoven, René
Kracht, Maria J. L.
van der Slik, Arno R.
Thomaidou, Sofia
Wolters, Anouk H. G.
Giepmans, Ben N. G.
Riojas, Juan Pablo Romero
Nelson, Michael S.
Carlotti, Françoise
de Koning, Eelco J. P.
Hoeben, Rob C.
Zaldumbide, Arnaud
Roep, Bart O.
Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells
title Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells
title_full Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells
title_fullStr Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells
title_full_unstemmed Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells
title_short Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells
title_sort presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036285/
https://www.ncbi.nlm.nih.gov/pubmed/36884057
http://dx.doi.org/10.1007/s00125-023-05882-y
work_keys_str_mv AT vantienhovenrene presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT krachtmariajl presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT vanderslikarnor presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT thomaidousofia presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT woltersanoukhg presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT giepmansbenng presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT riojasjuanpabloromero presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT nelsonmichaels presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT carlottifrancoise presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT dekoningeelcojp presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT hoebenrobc presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT zaldumbidearnaud presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells
AT roepbarto presenceofimmunogenicalternativelysplicedinsulingeneproductinhumanpancreaticdeltacells